VIBEKE STRAND
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology PORTOLA VALLEY, CA NPI 1194882753
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology CA E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$970,017.32
- Category: General Payments
- Program years: PY2018–2024
- Record count: 605
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $60,262.95 across 33 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $44,365.00 | 17 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,477.43 | 1 |
| Travel and Lodging | $6,753.78 | 4 |
| Food and Beverage | $666.74 | 11 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $17,936.77 | 12 |
| ABBVIE INC. | $11,200.00 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,477.43 | 1 |
| SWEDISH ORPHAN BIOVITRUM AB | $7,700.00 | 3 |
| Pacira Pharmaceuticals Incorporated | $5,040.00 | 1 |
| GlaxoSmithKline, LLC. | $3,250.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,100.00 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $2,100.00 | 2 |
| AstraZeneca UK Limited | $2,025.00 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $323.24 | 3 |
| Lilly USA, LLC | $44.01 | 1 |
| PFIZER INC. | $36.66 | 1 |
| SOBI, INC | $29.84 | 1 |
By program year
Records — PY2024 (33)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.